Colorectal Cancer
📧 Sign up to get email alerts when something new happens for Colorectal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-04-22Clinical Trial Update: Combined PD-1 and CCR5 Inhibition for the Treatment of Refractory Microsatellite Stable mCRC [Phase 1]
Phase 1 trial evaluating combined PD-1 and CCR5 inhibition for refractory microsatellite-stable metastatic colorectal cancer; results posted…
-
CLINICAL_TRIALS trial_result · 2021-04-20Clinical Trial Update: Celecoxib as Adjuvant Therapy to Chemotherapy in Patients With Metastatic Colorectal Cancer [Phase 4]
Phase 4 trial evaluating celecoxib as adjuvant therapy to chemotherapy in patients with metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer [Phase 2]
Phase 2 trial update on neoadjuvant FOLFOXIRI chemotherapy for patients with locally advanced colon cancer (colonic neoplasms).
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Neoadjuvant FOLFOXIRI Chemotherapy in Resectable Liver Metastasis of Colorectal Cancer [Phase 2]
Phase II trial update on neoadjuvant FOLFOXIRI chemotherapy for resectable liver metastases from colorectal cancer.
-
CLINICAL_TRIALS research · 2021-04-19Clinical Trial Update: Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors [NA]
A completed clinical trial from Wake Forest University Health Sciences evaluating systems support mapping to guide self-management in colore…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-13Clinical Trial Update: Evaluation of the Bowel Cleansing in Hospitalized Patients Using Pure-Vu System [NA]
Completed clinical trial evaluating bowel cleansing in hospitalized patients using the Pure-Vu System; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Regorafenib in Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating regorafenib in metastatic colorectal cancer has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: c-CetuIRI Versus Ersecond-line Irinotecan s-IRI-CetuIRI [Phase 2]
Phase 2 clinical trial update comparing c-CetuIRI versus second-line irinotecan in colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-25Clinical Trial Update: Neoadjuvant Electrochemotherapy for Colorectal Cancer - a Randomized Controlled Trial [Phase 1, Phase 2]
A randomized controlled trial evaluating neoadjuvant electrochemotherapy for colorectal cancer across Phase 1 and Phase 2 stages; current st…
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared to Best Supportive Care in Colorectal Cancer Patients [Phase 2]
Open-label Phase IIb efficacy trial of Cancer Macrobeads vs best supportive care in colorectal cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: ASPirin Intervention for the REDuction of Colorectal Cancer Risk [NA]
Update on a Massachusetts General Hospital trial evaluating aspirin to reduce colorectal cancer risk. Results were posted in March 2021, and…
-
CLINICAL_TRIALS trial_result · 2021-03-23Clinical Trial Update: Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer [Phase 4]
Phase 4 trial update exploring plasma biomarkers for aflibercept in recurrent or metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases [Phase 4]
Phase 4 trial comparing resection of the primary tumor versus no resection in colorectal cancer with unresectable metastases; study terminat…
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [NA]
Clinical trial update for metastatic colorectal cancer investigating combination chemotherapy with cetuximab or bevacizumab; the study is te…
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer [Phase 2]
Phase II trial of the CDK inhibitor PD 0332991 (palbociclib) in various adult solid tumors including colon and breast cancers has completed …
-
CLINICAL_TRIALS trial_result · 2021-03-11Clinical Trial Update: Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating a combination of hydroxychloroquine, capecitabine, oxaliplatin, and bevacizumab in metastatic colorectal can…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer [Phase 2]
Phase 2 trial update on tislelizumab plus anlotinib for immunotherapy-resistant gastric and colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Comparison of Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer [Phase 2]
A Phase 2 trial comparing combination chemotherapy regimens in metastatic colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer [Phase 3]
A Phase 3 trial evaluating Xilonix for symptomatic/advanced colorectal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: Study of Magrolimab (Hu5F9-G4) in Combination With Cetuximab in Participants With Solid Tumors and Advanced Colorectal Cancer [Phase 1, Phase 2]
Phase 1/2 study evaluating Magrolimab (Hu5F9-G4) with cetuximab in solid tumors and advanced colorectal cancer completed with results posted…
-
CLINICAL_TRIALS trial_result · 2021-03-01Clinical Trial Update: A Prospective Study Utilizing Circulating Cell Free DNA (cfDNA) Use in the Detection of RAS Mutations in Patients With Advanced Colorectal Cancer. [Phase 2]
Phase 2 clinical trial exploring circulating cell-free DNA for detecting RAS mutations in advanced colorectal cancer (Colorectal cancer).
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer [Phase 1]
Phase 1 trial update for OCV-C02 in advanced or relapsed colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer [Phase 2]
Phase 2 trial update evaluating capecitabine and oxaliplatin in older patients with metastatic colorectal cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) [Phase 2]
Open-label extension study of Conatumumab and Ganitumab (AMG 479) in a Phase 2 trial for advanced solid tumors; completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors [Phase 1, Phase 2]
Phase Ib/II clinical trial evaluating MEK162 with panitumumab in metastatic colorectal cancer with mutant or wild-type RAS; study completed …